Yanjiao Li granted 10 million in FRIPRO funds to improve IVF treatments

Improving IVF treatment

Yanjiao Li, researcher form the Department of Microbiology at Oslo University Hospital and CRESCO Centre for embryology and healthy development (UiO), has received 10 million Norwegian kroner in FRIPRO funding from the Research Council of Norway. FRIPRO is awarded for frontier research with the potential to push the boundaries of knowledge.

One in six people experiences infertility. Assisted reproductive technologies (ARTs)-babies now account for 6% of all newborns. Although in vitro fertilization (IVF) helps many, it still fails often. Only about half of the fertilized eggs grow into blastocysts, the stage where they are implanted in the uterus. Not every transferred embryo results in pregnancy.

Understanding the fundamental processes

With this project, Li and his collaborators aim to improve our understanding of fundamental biological processes that influence early embryo development and embryo quality. By combining expertise from reproductive medicine, molecular biology and embryology, the project seeks to generate new knowledge that may contribute to more effective and patient-friendly IVF treatments in the future.

The project will be carried out in close collaboration with the Department of Reproductive Medicine at Oslo University Hospital, and will be based at the Department of Microbiology (OUS) and the Centre of Excellence CRESCO – Centre for Embryology and Healthy Development.

Links:

Reproductive Medicine Group, headed by Peter Fedorcsak

Laboratory for Dynamic Gene regulation, headed by Arne Klungland

Yanjiao Li

Centre for Embryology and Healthy Development (CRESCO)

From the University of Oslo (in Norwegian):
FRIPRO-suksess for UiOs forskere

From the Research Council of Norway (in Norwegian):
374 millionar kroner til banebrytande forskarar